Eledon Pharmaceuticals Inc

NASDAQ:ELDN   3:59:53 PM EDT
4.08
-0.07 (-1.69%)
Earnings Announcements

Eledon Pharmaceuticals Posts Q3 Loss Per Share Of $0.66

Published: 11/11/2021 22:13 GMT
Eledon Pharmaceuticals Inc (ELDN) - Eledon Pharmaceuticals Reports Third Quarter 2021 Operating and Financial Results.
Q3 Loss per Share $0.66.
Q3 Earnings per Share View $-0.65 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.75

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.55

More details on our Analysts Page.